Company Active LTD

Company profile

Forsite Diagnostics Limited

Abingdon Health | Lateral Flow Test Manufacture and Development

Assay development and high-volume lateral flow test contract manufacturing. Helping you move faster, contain risks and embrace opportunities

CRN
05696673
Founded
2006
Age
20

Overview

Legal name
FORSITE DIAGNOSTICS LIMITED
Region
Yorkshire and the Humber
Registered address
YORK BIOTECH CAMPUS
SAND HUTTON
YORK
ENGLAND
YO41 1LZ
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller
1
Company Active LTD
Forsite Diagnostics Limited
CRN 05696673
2
Direct and ultimate controller Active PLC
Abingdon Health PLC
CRN 06475379

Latest accounts

Financial period: 1 Jul 2024 to 30 Jun 2025

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
-£1,156,877
Employees
54

Company events

Reference milestones and recent Companies House filing stream events.

7 events
31 Mar
2027

Accounts due

Accounts Due

Next accounts due date

17 Feb
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

03 Feb
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Jun
2025

Accounts filed

Accounts

Last accounts made up date

27 Nov
2024

Accounts With Accounts Type Full

Accounts Analysed

AA | Transaction MzQ0NTE0NjEyMmFkaXF6a2N4

Published 27 Nov 2024 02:54

04 Oct
2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQzODQxODQyM2FkaXF6a2N4

Published 04 Oct 2024 10:42

03 Feb
2006

Incorporated

Inception

Company registered at Companies House

Public funding

8 awards
First funded
2010
Funded years
2010, 2012, 2013, 2025
Age at first award
4 years

Projects

2025 EU-Funded Lead participant

A point-of-care serological rapid diagnostic test for risk of Plasmodium vivax hypnozoite infection

1 Feb 2025 to 31 Jan 2030

Awarded
£830,952
Total cost £830,952

Plasmodium vivax is considered the most difficult species of human malaria parasite to eliminate because of the inability of conventional diagnostics to detect individuals who carry dormant liver forms and sustain malaria transmission. The consortium has developed the first diagnostic test that addresses this problem. PvSeroRDT aims to develop a point-of-...

2013 Collaborative R&D

Development of a pen-side test for liver fluke in cattle and sheep.

1 Oct 2013 to 30 Sep 2016

Awarded
£60,725
Total cost £101,209

Fasciolosis is a major disease of cattle and sheep and is a key problem within the farming industry. It is caused by the parasite, Fasciola hepatica (a liver fluke), and is acquired by the ingestion of water or vegetation contaminated by the infectious stage of the parasite. The parasite goes on to colonise the liver of cattle and sheep where they feed on...

2013 Collaborative R&D

A pen side test for Schmallenberg virus exposure in sheep and cattle.

1 Sep 2013 to 30 Nov 2015

Awarded
£55,849
Total cost £93,081

Since its emergence in 2011, Schmallenberg virus (SBV) has spread across most of the European continent. The virus causes a mild disease in adult sheep and cattle (fever, reduced milk yield and diarrhoea). However if an animal is infected during pregnancy, resultant offspring can have severe deformities. SBV is spread by biting midges making efforts to co...

2012 Feasibility Studies Lead participant

Incorporating aptamers into lateral flow devices to evaluate their use in the manufacturing of on-site test kits

1 Aug 2012 to 30 Nov 2012

Awarded
£12,409
Total cost £16,546

Two Yorkshire based companies (Forsite Diagnostics Ltd and Aptamer Solutions Ltd) aim to collaborate through this feasibility study, to bring their individual expertise and harness the use of aptamers within routine development and subsequent and large scale production of lateral flow devices. If successful the methodologies developed will enable the rout...

2012 Collaborative R&D

PROMPT SEPSIS : Partnership for Rapid On-site Microfluidic POC Test for Sepsis ¬¬¬

1 Jun 2012 to 30 Sep 2014

Awarded
£60,004
Total cost £179,600

Sepsis, a severe illness in which the bloodstream is overwhelmed by bacteria, affects 18 million people worldwide annually. Symptoms can be non-specific so there are often delays in diagnosis. It is rapidly progressive illness which, if untreated can result in major organs and body systems not functioning and eventually, death. In the UK, sepsis affects u...

2012 Collaborative R&D

Development of in-farm diagnostic tests for Campylobacter

1 Mar 2012 to 28 Feb 2014

Awarded
£9,998
Total cost £40,169

Background The research work is being undertaken by a consortium of research and industry based technologists, scientists and poultry producers. The aim is to develop a rapid test system that can be used with great accuracy to evaluate on the farm whether the flock is carrying in its visceral tract the campylobacter’s of C Jejuni or C Coli. The bacterium ...

2010 Collaborative R&D

Seed to store:a holistic approach to controlling internal rots in onion

1 Sep 2010 to 31 Aug 2013

Awarded
£1,584
Total cost £15,846

Project Description UK onion growers have invested heavily in technologically advanced drying, curing, refrigeration and controlled atmosphere storage systems designed to maintain availability of UK onions for up to 10 months, with gross annual production of around 400,000 tonnes, over 50% of UK annual consumption. The storage systems are effective in pro...

2010 Feasibility Studies Lead participant

Develop and evaluate a next generation portable POC lateral flow device reader for use at infectious disease outbreak sites

1 Jun 2010 to 31 Aug 2011

Awarded
£86,250
Total cost £115,000

Awaiting Public Summary

Product types

Collaborative R&D EU-Funded Feasibility Studies